CARR Biosystems Acquires Alfa Wassermann
August 14, 2026
CARR Biosystems has acquired Alfa Wassermann (AW), a leader in continuous flow ultracentrifugation and fluid handling solutions, to expand its bioprocessing and separations portfolio. The transaction closed on August 10, with AW continuing to provide sales, service, engineering, and operational support from its U.S. and European operations.
- Buyers
- CARR Biosystems
- Targets
- Alfa Wassermann (AW)
- Sellers
- Turytes S.p.A.
- Industry
- Healthcare Services
- Location
- Florida, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.